FDA receives new reports of issues with Essure birth control device

(Reuters) – The U.S. Food and Drug Administration is investigating new reports of Bayer’s implanted birth control device Essure causing problems during removal, the agency said on Wednesday, two years after it slapped a warning label on the product.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply